Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
The bedaquiline–pretomanid–linezolid regimen has been reported to have 90% efficacy against highly drug-resistant tuberculosis, but the incidence of adverse events with 1200 mg of linezolid daily has been high
15.01.2023 ,16:50